Skip to main content
China Biotech Services Holdings Limited logo

China Biotech Services Holdings Limited — Investor Relations & Filings

Ticker · 8037 HKEX Human health and social work activities
Filings indexed 1,385 across all filing types
Latest filing 2026-05-04 Regulatory Filings
Country HK Hong Kong
Listing HKEX 8037

About China Biotech Services Holdings Limited

http://www.cbshhk.com

China Biotech Services Holdings Limited operates as an investment holding company with diversified interests primarily focused on the healthcare sector. The company's core activities include the provision of medical laboratory testing and comprehensive health check services, serving markets such as the People's Republic of China. Its operations encompass a pathology laboratory providing third-party medical testing, recognized as one of Hong Kong's largest providers in this domain, boasting a history of over 54 years. Furthermore, the company maintains a Pharmaceutical Products segment dedicated to the research, development, manufacture, sale, and distribution of health-related and pharmaceutical products. It also engages in investment activities, including real estate.

Recent filings

Filing Released Lang Actions
COMPANY INFORMATION SHEET
Regulatory Filings
2026-05-04 English
List of Directors and their Role and Function
Regulatory Filings
2026-05-04 English
RESIGNATION OF EXECUTIVE DIRECTOR
Regulatory Filings
2026-04-30 English
Notification Letter to Non-Registered Shareholders
Report Publication Announcement Classification · 1% confidence The document is a notification letter to non-registered shareholders that the company’s Annual Report 2025 has been published on its website and the HKEX website, and explains how to request printed copies. It does not contain the report itself but announces its publication. Under the “menu vs meal” rule, this is a Report Publication Announcement (RPA).
2026-04-29 English
Notification Letter to Registered Shareholders and Reply Form
Report Publication Announcement Classification · 1% confidence The document is a short notification letter informing shareholders that the Annual Report 2025 is available on the company’s and exchange websites, providing links and instructions for accessing or requesting printed copies. It does not contain the report itself nor detailed financials, but merely announces publication of the report. This matches the definition of a Report Publication Announcement (RPA).
2026-04-29 English
ANNUAL REPORT 2025
Annual Report Classification · 1% confidence The document is the full annual report for China Biotech Services Holdings Limited for the year ended 31 December 2025, including corporate information, chairman’s statement, MD&A, corporate governance, ESG report, directors’ report, independent auditor’s report, full consolidated financial statements and notes. It is not merely an announcement or summary but the complete Annual Report. Therefore, it matches the Annual Report category. FY 2025
2026-04-29 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.